financetom
Business
financetom
/
Business
/
Amneal's Combination Drug Shows Improved Sleep Quality In Parkinson's Disease Patients
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amneal's Combination Drug Shows Improved Sleep Quality In Parkinson's Disease Patients
Apr 7, 2025 1:05 PM

Amneal Pharmaceuticals, Inc. ( AMRX ) revealed a new analysis of the pivotal RISE-PD Phase 3 study on Monday.

The data showed that patients who converted to Crexont from immediate release (IR) carbidopa/levodopa (CD/LD) experienced improved sleep quality.

These improvements were measured by their Parkinson’s Disease Sleep Scale-2 (PDSS-2) total scores, showing a mean difference of -2.35 (p

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved